SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Mylan Labs -- Ignore unavailable to you. Want to Upgrade?


To: mr.bill who wrote (302)5/2/1998 12:11:00 PM
From: Druggist  Read Replies (1) | Respond to of 384
 
I think that Merck, Lilly, everyone took a hit in unison.. But at least Mylan recovered very nicely...

I bought into Schein Pharmaceuticals last week, it was an IPO that
was offered at 23, ran to 25ish then back to 23... its now at
24 ish... Very similar to Mylan in product line, etc... I think a good one to put away...

Druggist

ps Schein is SHP